Efficacy Assessment of the Co-Administration of Vancomycin and Metronidazole in Clostridioides difficile -Infected Mice Based on Changes in Intestinal Ecology
Journal of Microbiology and Biotechnology · 2024
DOI: 10.4014/jmb.2312.12034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2024. Verfasst von Saiwei Zhong und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, P.R. China. Hauptthemen laut MEDLINE: Metronidazole, Vancomycin, Clostridium Infections, Gastrointestinal Microbiome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Vancomycin (VAN) and metronidazole (MTR) remain the current drugs of choice for the treatment of non-severe Clostridioides difficile infection (CDI); however, while their co-administration has appeared in clinical treatment, the efficacy varies greatly and the mechanism is unknown. In this study, a CDI mouse model was constructed to evaluate the therapeutic effects of VAN and MTR alone or in combination. For a perspective on the intestinal ecology, 16S rRNA amplicon sequencing and non-targeted metabolomics techniques were used to investigate changes in the fecal microbiota and metabolome of mice under the co-administration treatment. As a result, the survival rate of mice under co-administration was not dramatically different compared to that of single antibiotics, and the former caused intestinal tissue hyperplasia and edema. Co-administration also significantly enhanced the activity of amino acid metabolic pathways represented by phenylalanine, arginine, proline, and histidine, decreased the level of deoxycholic acid (DCA), and downregulated the abundance of beneficial microbes, such as Bifidobacterium and Akkermansia. VAN plays a dominant role in microbiota regulation in co-administration. In addition, co-administration reduced or increased the relative abundance of antibiotic-sensitive bacteria, including beneficial and harmful microbes, without a difference. Taken together, there are some risks associated with the co-administration of VAN and MTR, and this combination mode should be used with caution in CDI treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, P.R. China.
- School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, P.R. China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhong, S., Yang, J., & Huang, H. (2024). Efficacy Assessment of the Co-Administration of Vancomycin and Metronidazole in Clostridioides difficile -Infected Mice Based on Changes in Intestinal Ecology. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2312.12034
Vancouver
Zhong S, Yang J, Huang H. Efficacy Assessment of the Co-Administration of Vancomycin and Metronidazole in Clostridioides difficile -Infected Mice Based on Changes in Intestinal Ecology. Journal of Microbiology and Biotechnology. 2024. doi:10.4014/jmb.2312.12034
BibTeX
@article{Zhong2024,
author = {Zhong, Saiwei and Yang, Jingpeng and Huang, He},
title = {Efficacy Assessment of the Co-Administration of Vancomycin and Metronidazole in Clostridioides difficile -Infected Mice Based on Changes in Intestinal Ecology},
journal = {Journal of Microbiology and Biotechnology},
year = {2024},
doi = {10.4014/jmb.2312.12034}
}
EUVIMED